Peter Homberg specializes in life sciences, IP and corporate law, and M&A transactions. He particularly advises companies in the pharmaceutical, diagnostics, medical device and biotechnology sectors on research and development contracts, collaboration agreements, cross-border IP licensing and IP strategies. He also has extensive experience in advising on compliance issues and…
View moreRelated Matters Nuuvera/Aphria Deutschland GmbH: Advising Aphria Deutschland GmbH on securing licenses for the cultivation, processing and transfer of cannabis for medical purposes in Germany, and Nuuvera on all regulatory matters of its German operations related to the takeover by Aphria Materia: Advising Materia on the acquisition of all…
View more